Cogent Biosciences (NASDAQ:COGT) and ModivCare (NASDAQ:MODV) were among the notable gainers on Wednesday after their insiders disclosed the recent purchases of companies’ stock.
Cogent Biosciences (NASDAQ:COGT) climbed ~10% after Cole Pinnow, its newly appointed chief commercial officer, bought 43,750 shares